Motor Dysfunction in REM Sleep Behavior Disorder: A Rehabilitation Framework for Prodromal Synucleinopathy.
Rebekah L S Summers, Miriam R Rafferty, Michael J Howell and 1 others
PMID 33978530WHAT IT FOUND
People with isolated REM sleep behavior disorder often show subtle motor signs years before a Parkinson's diagnosis.
The authors propose a framework for early exercise and rehabilitation, but note there are no trials proving these interventions prevent or slow the disease.
Key findings
01Subtle motor signs like bradykinesia and gait changes appear years before clinical diagnosis in people with isolated REM sleep behavior disorder.
02The authors propose a framework for early exercise and rehabilitation, but acknowledge there is no evidence that these interventions prevent or slow disease progression.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTsWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The paper is a theoretical framework and expert opinion, not a clinical trial or systematic review with meta-analysis. The authors admit there are no longitudinal studies using instrumented measures of bradykinesia, gait, or speech in iRBD to validate their proposed monitoring strategy. The recommendations for exercise and rehabilitation are extrapolated from animal models and studies in people who already have Parkinson's disease, not from trials in people with iRBD. The authors state clearly that it is unknown whether exercise can halt or mitigate the neurodegenerative process in alpha-synucleinopathy.
Declared interests
The authors declare no conflict of interest.
The easy way to misread this
Do not interpret the proposed rehabilitation framework as evidence that exercise prevents or slows Parkinson's disease in people with REM sleep behavior disorder. The authors state that no interventions are currently known to delay disease onset, and the framework is a hypothesis for future research, not a validated treatment protocol.